NVBG Sub Registers Aramark For AM500 Use By Service Master Unit
ATLANTA, Dec 15, 2003 (BUSINESS WIRE) -- Nova BioGenetics (OTC Bulletin Board: NVBG) announces it has sub registered Aramark for use of AM500 for their Service Master Unit. Nova has been working on this arrangement for some time and has completed the sub registration to now allow the use of AM500 for Service Master.
About Nova BioGenetics:
Nova BioGenetics, Inc., ("Nova"), is a biopharmaceuticals company headquartered in Atlanta, Georgia. Nova is engaged in the discovery, development, and commercialization of new therapeutic agents that treat life-threatening infectious diseases. Nova BioGenetics' pipeline, for both FDA and EPA regulatory agencies, is based on patented technology and Nova's own initial bench studies used as a broad base for applications with existing antibiotic compounds. Attaching the patented technology with antibiotic compounds has proven to facilitate potential disruption of bacterial agents thus producing new therapeutic agents to be marketed.
While the company is specifically focused on its biopharmaceutical interests and is presently in a development stage, Nova also operates a division within the company that is responsible for the sale of cutting edge patented and EPA approved antimicrobials and biocides. Nova currently has contracted with eight (8) specialty chemical representative agencies with over sixty three (63+) sales agents in the U.S. to market its diverse line of products for that division. Continued expansion, particularly in the overseas markets, is part of the company's marketing strategy.
Further information on Nova and its line of products can be found by visiting the company's web site at www.novaBioGenetics.com, Ph.# 770-650-6508, Fax # 770-650-0411, or for investor information, contact Todd Smith, Dir. of Investor Relations.
SOURCE: Nova BioGenetics, Inc.
CONTACT: Nova BioGenetics, Atlanta
Todd Smith, 770-650-6508
The best weapon against "fear" is "facts"!!
